Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiomic analysis reveals conservation of cancer-associated fibroblast phenotypes across species and tissue of origin
Deshka S. Foster, Michael Januszyk, Daniel Delitto, et al.
Cancer Cell (2022) Vol. 40, Iss. 11, pp. 1392-1406.e7
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1539
Fibroblasts in cancer: Unity in heterogeneity
Yash Chhabra, Ashani T. Weeraratna
Cell (2023) Vol. 186, Iss. 8, pp. 1580-1609
Closed Access | Times Cited: 197
Define cancer-associated fibroblasts (CAFs) in the tumor microenvironment: new opportunities in cancer immunotherapy and advances in clinical trials
Hao Zhang, Xinghai Yue, Zhe Chen, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 146
Roles of cancer-associated fibroblasts (CAFs) in anti- PD-1/PD-L1 immunotherapy for solid cancers
Liping Pei, Yang Liu, Lin Liu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 115
Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects
Saket Jain, Jonathan W. Rick, Rushikesh S. Joshi, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 5
Open Access | Times Cited: 97
Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer
Lena Cords, Stefanie Engler, Martina Haberecker, et al.
Cancer Cell (2024) Vol. 42, Iss. 3, pp. 396-412.e5
Open Access | Times Cited: 94
Localization, tissue biology and T cell state — implications for cancer immunotherapy
Jason M. Schenkel, Kristen E. Pauken
Nature reviews. Immunology (2023) Vol. 23, Iss. 12, pp. 807-823
Open Access | Times Cited: 62
Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapy
Ziyi Li, Rhea Pai, Saurabh Gupta, et al.
Nature Cancer (2024) Vol. 5, Iss. 1, pp. 167-186
Open Access | Times Cited: 40
Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer
Hugo Croizer, Rana Mhaidly, Yann Kieffer, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 32
Cancer-associated fibroblasts: a versatile mediator in tumor progression, metastasis, and targeted therapy
Tianchen Guo, Junfen Xu
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 1095-1116
Open Access | Times Cited: 29
Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation
Yang Gao, Jianan Li, Wenfeng Cheng, et al.
Cancer Cell (2024)
Open Access | Times Cited: 24
Integration Analysis of Single‐Cell Multi‐Omics Reveals Prostate Cancer Heterogeneity
Xiaojie Bian, Wenfeng Wang, Mierxiati Abudurexiti, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 23
Single-cell sequencing to multi-omics: technologies and applications
Xiangyu Wu, Xin Yang, Yunhan Dai, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Crosstalk between cancer-associated fibroblasts and regulated cell death in tumors: insights into apoptosis, autophagy, ferroptosis, and pyroptosis
Cong Chen, Jian Liu, Xia Lin, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 16
Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy
Zhongsong Zhang, Rong Wang, Long Chen
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 483-503
Open Access | Times Cited: 3
Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
Zhongsong Zhang, Long Chen
Cancer Nanotechnology (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
The diverse nature of intestinal fibroblasts in development, homeostasis, and disease
Michael David Brügger, Konrad Basler
Trends in Cell Biology (2023) Vol. 33, Iss. 10, pp. 834-849
Open Access | Times Cited: 40
Clinical and translational relevance of intratumor heterogeneity
Marie-Anne Goyette, Marla Lipsyc-Sharf, Kornélia Polyák
Trends in cancer (2023) Vol. 9, Iss. 9, pp. 726-737
Open Access | Times Cited: 25
Cancer-Associated Fibroblast Heterogeneity and Its Influence on the Extracellular Matrix and the Tumor Microenvironment
Karl Knipper, Su Ir Lyu, Alexander Quaas, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13482-13482
Open Access | Times Cited: 23
Single‐cell RNA sequencing elucidated the landscape of breast cancer brain metastases and identified ILF2 as a potential therapeutic target
Jindong Xie, Anli Yang, Qianwen Liu, et al.
Cell Proliferation (2024) Vol. 57, Iss. 11
Open Access | Times Cited: 13
POSTN+cancer-associated fibroblasts determine the efficacy of immunotherapy in hepatocellular carcinoma
Hao Wang, Yuan Liang, Zheng Liu, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 7, pp. e008721-e008721
Open Access | Times Cited: 13
YAP1 Inhibition Induces Phenotype Switching of Cancer-Associated Fibroblasts to Tumor Suppressive in Prostate Cancer
Hongtao Song, Tong Lü, Donghui Han, et al.
Cancer Research (2024) Vol. 84, Iss. 22, pp. 3728-3742
Open Access | Times Cited: 11
Epigenomic heterogeneity as a source of tumour evolution
Marthe Laisné, Mathieu Lupien, Céline Vallot
Nature reviews. Cancer (2024)
Closed Access | Times Cited: 9
Single-cell Transcriptomics Reveals Intratumor Heterogeneity and the Potential Roles of Cancer Stem Cells and myCAFs in Colorectal Cancer Liver Metastasis and Recurrence
Zhan Yao, Dong Sun, Jie Gao, et al.
Cancer Letters (2025), pp. 217452-217452
Closed Access | Times Cited: 1
Stromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma
Yifei Cheng, Xiaofang Chen, Feng Li, et al.
Cell Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top